Evaluating Lipiodol Embolization for Hand Osteoarthritis Pain Relief
Official title: Evaluation of the Safety of LipiodolⓇ Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment: a Pilot Study of 15 Patients
Run by University Hospital, Grenoble · NCT06611007 · Data updated 2026-11-12
This study is testing whether a procedure using Lipiodol can help relieve pain and improve hand function in people with osteoarthritis who haven't found relief from standard treatments.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 1 site (Échirolles) |
| Status | Recruiting |
| Started | January 30, 2025 |
| Main results expected | July 15, 2028 |
| Study ends | July 15, 2028 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT06611007 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 40 and older with symptomatic hand osteoarthritis that has not adequately responded to standard treatments.
✕Probably not a fit
Patients with a history of allergy to iodinated contrast media or those with severe vascular disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to assess the safety and efficacy of arterial embolization using Lipiodol® in patients suffering from symptomatic hand osteoarthritis that has not responded to conventional treatments. Participants will undergo the embolization procedure and will be monitored over a six-month period for pain relief, hand function improvement, and any potential side effects. The study will also include imaging studies to evaluate changes in joint vascularization and damage. The primary focus is to determine the safety profile of Lipiodol® and its effectiveness in alleviating symptoms of osteoarthritis.
Why it matters
Potential benefit: If successful, this treatment could provide significant pain relief and improved hand function for patients with refractory hand osteoarthritis.
How similar studies have gone: While the approach of using embolization for osteoarthritis is relatively novel, similar studies in other conditions have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged ≥ 40 years. * Osteoarthritis of the hand according to American College of Rheumatology criteria 1990 * Osteoarthritis affecting at least two proximal and/or distal interphalangeal joints with a radiological Kellgren-Lawrence stage ≥ 2. * Symptomatic osteoarthritis within the last 3 months. * Visual analogue pain scale of the hand to be treated ≥ 40/100 mm (most painful hand). * Inadequate response, adverse effects and/or contraindication to NSAIDs and non-opioid analgesics. * Patient affiliated to french social security or a similar health assurance. Exclusion Criteria: * History of allergy to iodinated contrast media, LipiodolⓇ or poppies. * Vasomotor disorders (Raynaud\'s syndrome, scleroderma, acrocyanosis). * Stenosis (\>50%) or known atheromatous arterial occlusion of the upper limbs. * Obliterative arterial disease of the lower limbs at the critical ischaemia stage. * Severe to end-stage chronic renal insufficiency (glomerular filtration rate \< 30ml/min/1.73m2), dialysis or renal transplant. * Arteritis such as thromboangiitis obliterans disease or other diseases * Previous thrombosis/dissection of the radial artery. * Chronic inflammatory rheumatic disease (rheumatoid arthritis, psoriatic arthritis, microcrystalline arthritis, etc.). * Known hyperthyroidism or large multinodular goiter. * Traumatic lesions, haemorrhages or chronic bleeding in the hand (not completely resolved within 3 months of the start of the lesion) requiring embolisation. * Pregnant or breast-feeding. * Patients covered by articles L1121-5 to L1121-8 of the French Public Health Code and/or who do not speak French. * Patients in a period of exclusion or in the course of another interventional clinical trial.
Where it's running
-
CHU Grenoble Alpes - Sud site
Échirolles, France Recruiting
Study contacts
- Principal investigator: Xavier Romand, MD, PhD — CHU Grenoble Alpes, site Sud, France
- Study coordinator: Xavier Romand, MD, PhD
- Email: xromand@chu-grenoble.fr
- Phone: 0476767223
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Early wear of a Vitamin E-infused liner in a dual-mobility hip replacement
This study tests whether a Vitamin E-infused liner in a dual-mobility hip implant wears as little as a conventional liner over two years in adults needing hip replacement.
-
Preoperative Music to Ease Anxiety Before Hip or Knee Replacement
Patients awaiting hip or knee replacement listen to their own music through noise‑canceling headphones to see if it lowers preoperative anxiety.
-
Weight-bearing dangling exercises vs VMOb NMES for knee osteoarthritis
This study tests whether weighted dangling exercises or VMOb muscle NMES help people with knee osteoarthritis.
-
Post-op prednisone vs standard steroid regimen after knee or hip replacement
This study tests a 5-day oral prednisone course after knee or hip replacement to see if pain, swelling, and glucose control are better or different than the usual intraoperative steroid approach.
-
AI-based prediction of five major diseases using integrated health data
Researchers are testing an AI model to see if they can predict the onset of five major diseases in adults 30–65 by combining medical records with biospecimens and lifestyle data.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.